Denali Therapeutics
Focus: Denali Therapeutics is a 5,000+ employee biotech company headquartered in South San Francisco specializing in neurodegenerative disease therapies with proprietary blood-brain barrier (BBB)-crossing antibody technology.
Profile data last refreshed Yesterday · AI intelligence enriched 2mo ago
Employees
5000+
Open Jobs
0
About Denali Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Denali Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
No Intervention
Mucopolysaccharidosis IIClinical Trials (1)
NCT04007536A Study of Potential Treatment-Responsive Biomarkers and Clinical Outcomes in Hunter Syndrome
N/AHelp build intelligence for Denali Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.